| Ονομασ?α του προ??ντο? |
protected meropenem |
| Αγγλικ? ?νομα |
protected meropenem; 4-nitrobenzyl (5s,6s)-3-[((3s,5s)-5-[(dimethylamino)carbonyl]-1-{[(4-nitrobenzyl)oxy]carbonyl}pyrrolidinyl)sulfanyl]-6-[(1r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate; Meropenem & Intermediates Protected Meropenem P-NITROBENZYL(4R,5S,6S)-3-[(3S,5S)-(5-DIMETHYLAMINOCARBONYL-1-P-NITROBENZYLOXYCARBONYL)-PYRROLIDIN-3-YLSULFANYL]-6-((R)-1-HYDROXY-ETHYL)-4-METHYL-7-OXO-1-AZA-BICYCLO[3.2.0]HEPT-2ENE-4-CARBOXYLATE; intermediate of meropenem; 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; 3-(((3S,5S)-5-((dimet hylamino)carbonyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-(4R,5S,6S)-1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid; 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-(4R-(3(S*,5S*); 4-alpha,5-beta,6-beta(R*))); Antibiotic SM 7338; BRN 6940582; ICI 194660; Merrem; SM 7338; Meropenem protected; n-1; 4-nitrobenzyl (4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)-1-{[(4-nitrobenzyl)oxy]carbonyl}pyrrolidin-3-yl]sulfanyl}-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate |
| MF |
C32H35N5O11S |
| Μοριακ? β?ρο? |
697.71 |
| InChI |
InChI=1/C32H35N5O11S/c1-17-26-25(18(2)38)30(40)35(26)27(31(41)47-15-19-5-9-21(10-6-19)36(43)44)28(17)49-23-13-24(29(39)33(3)4)34(14-23)32(42)48-16-20-7-11-22(12-8-20)37(45)46/h5-12,17-18,23-26,38H,13-16H2,1-4H3/t17-,18-,23?,24+,25-,26-/m1/s1 |
| CAS ΟΧΙ |
96036-02-1 |
| Μοριακ? δομ? |
|
| Πυκν?τητα |
1.49g/cm3 |
| Σημε?ο τ?ξη? |
150-153℃ (dec.) |
| Σημε?ο βρασμο? |
900.3°C at 760 mmHg |
| Δε?κτη? δι?θλαση? |
1.672 |
| Σημε?ο αν?φλεξη? |
498.3°C |
| Π?εση ατμ?ν |
6.99E-35mmHg at 25°C |
| Σ?μβολα επικινδυν?τητα? |
|
| Κινδ?νου Κ?δικε? |
|
| Περιγραφ? τη? ασφ?λεια? |
|
|
GR
CN
CZ
DE
EN
ES
FR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
